Cardiovascular Disease in Patients With Type 2 Diabetes: A Qualitative Analysis of Knowledge, Attitudes, and Beliefs of Health Care Professionals. Issue 3 (July 2021)

• Record Type: Journal Article
• Authors: Ciemins, Elizabeth L.; McKinnon, Monette; Hamersky, Carol Mahler; Iyer, Neeraj N.; Powelson, Jill
• Is Part Of: Journal of ambulatory care management. Volume 44:Issue 3(2021)
• Publication Date: 2021-07
• Subjects: cardiovascular disease -- clinical guidelines -- diabetes -- evidence-based care; Ambulatory medical care -- Administration -- Periodicals; Ambulatory medical care -- United States -- Administration -- Periodicals; Community health services -- Administration -- Periodicals; Community health services -- United States -- Administration -- Periodicals; Health planning -- Periodicals; Health planning -- United States -- Periodicals; 362.12
• DOI: 10.1097/JAC.0000000000000379
• Languages: English
• ISSNs: 0148-9917

Abstract

Abstract : Guidelines for the management of patients with type 2 diabetes mellitus (T2DM) recommend SGLT-2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 RAs (glucagon-like peptide 1 receptor agonists) as second-line agents for patients with, or at risk for, cardiovascular disease. A better understanding of guideline implementation will further the provision of evidence-based health care to patients. Interviews and surveys of clinicians were conducted to understand providers' knowledge, attitudes, and beliefs related to the 2019 American Diabetes Association Standards of Care for T2DM. There was a lack of widespread knowledge of the guidelines and comfort with their use. Clinicians require additional training and education on the efficacy of the new medications and accompanying clinical guidelines. Abstract : Supplemental Digital Content is Available in the Text.